Switch View
© PR Newswire
13.10.2025
ISIN: US6707031075
Nuvalent Inc
NUVL
LISTED
NASDAQ
Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
CAMBRIDGE, Mass., Oct. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced an upcoming poster presentation further characterizing the preclinical intracra...
Themefolio
Profiler
Peergroup
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis
News Preview
Leuven, BELGIUM, October 13, 2025, 6:30 PM – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company based in Leuven, announces the signing of a letter of intent (LOI) to acquire a majority stake in a French Contract Research Organization (CRO) specialized in clinical development and regulatory affairs. This potential transaction is...
Themefolio
Profiler
Peergroup
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO dotée d'une forte complémentarité avec Axiodis
News Preview
Louvain, BELGIQUE – 13 octobre 2025 – 18h30 – Oxurion NV (Euronext Bruxelles : OXUR), société biopharmaceutique basée à Louvain, annonce la signature d'une lettre d'intention (LOI) en vue de l'acquisition d'une participation majoritaire dans une Contract Research Organization (CRO) fran&...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ActuNews
13.10.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een CRO die sterk complementair is aan Axiodis
News Preview
Leuven, BELGIË, 13 oktober 2025, 18u30 – Oxurion NV (Euronext Brussel: OXUR) kondigt vandaag de ondertekening aan van een intentieverklaring (Letter of Intent, LOI) met het oog op de overname van een meerderheidsbelang in een Franse Contract Research Organization (CRO), gespecialiseerd in klinische ontwikkeling en regelgevende aangelegen...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
13.10.2025
ISIN: US2214133058
Cosmos Health Inc
COSM
LISTED
NASDAQ
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
News Preview
CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $300,000 worth of Ethereum (ETH), increasing its total investment in ETH to $1.8 million....
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that a late-breaking abstract (LBA) featuring new data from its global Phase 1 clinical trial (NCT06179069) evaluating zocilurtatug pelitecan (zoci), formerly known as ZL-1310, has been selected for an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets an...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
News Preview
- Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable and who have received at least one approved systemic therapy
NORTH CHICAGO, Ill., Oct. 13, 202...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Merus kondigt de selectie aan van het abstract: Petosemtamab in Metastatic Colorectal Cancer (petosemtamab in gemetastaseerde colorectale kanker) voor mondelinge presentatie in de plenaire sessie op de AACR-NCI-EORTC International Conference on Molecular
News Preview
- Mondelinge presentatie plenaire sessie: vrijdag 24 oktober 10.00 - 11.40 uur. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
News Preview
SALT LAKE CITY, Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today its participation in the upcoming 2025 Maxim Growth Summit, taking place...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), have until December 2, 2025 to seek appointment as lead...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US2307701092
Cumberland Pharmaceuticals, Inc.
CPIX
LISTED
NASDAQ
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
News Preview
Premier Membership includes 4,350 U.S. Hospitals
NASHVILLE, Tenn., Oct. 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, has added their potent antibiotic, Vibativ® (telavancin), to a national group pur...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
13.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Lantheus class action lawsuit – captioned Margolis v. Lantheus Holdings, Inc., No. 25-cv-07491 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securiti...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH LAWSUIT ALERT: The Gross Law Firm Notifies Lantheus Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Nutex Health Inc.(NUTX) Shareholders
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
November 17, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against CYTK
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Class Action: The Gross Law Firm Reminds Semler Scientific, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Shareholders of LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026
News Preview
SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™) to profoundly improve people's lives, today announced that the Company completed a positive pre-B...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.10.2025
ISIN: US42227W1080
Healthcare Triangle, Inc.
HCTI
LISTED
NASDAQ
Healthcare Triangle Plays Offense to Redefine What Aggressive Growth Looks Like (NASDAQ: HCTI)
News Preview
PLEASANTON, CA / ACCESS Newswire / October 13, 2025 / Healthcare Triangle Inc. (NASDAQ:HCTI) published a recent press release that included a headline that could've been mistaken for corporate filler- "executes aggressive growth." But this one hits different. What sounds routine is actually a signal. With a market cap of just $16 million,...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US9418481035
Waters Corp
WAT
LISTED
NYSE
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
News Preview
Headlines:
Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1
Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between emp...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US03475V1017
AngioDynamics Inc
ANGO
LISTED
NASDAQ
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List
News Preview
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its NanoKnife System has been selected as one of TIME's 2025 Best Inventions. The annual list celebrates groundbreakin...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will demonstrate progress in our commitment to transform how cancer is treated with new data at the European Society for Medical Oncology (ESMO) 2025 Congress October 17 – 21.
Potentially Practice-Changing Results for First-Line Metastatic TNBC Treatment
A late-breaking presentat...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US9418481035
Waters Corp
WAT
LISTED
NYSE
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
News Preview
Headlines:
Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1
Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between emp...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US9418481035
Waters Corp
WAT
LISTED
NYSE
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
News Preview
Headlines:
Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1
Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between emp...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
News Preview
30-day Data from the AMDS PERSEVERE Trial Demonstrates Visceral Malperfusion Resolution in 83%, and Renal Malperfusion Resolution in 74% of Affected Subjects Post-AMDS Implantation
Real-World Data from the AMDS PROTECT Trial Validate Statistically Significant Po...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Florida State University has selected GeneDx as one of its partners for the recently passed Sunshine Genetics Act, a groundbreaking initiative establishing the nation’s first state-backed genomic newborn screening (gNBS) program.
The S...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera to Host Investor Call on October 23, 2025 to Discuss ESMO Findings
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will host a conference call and webcast on Thursday, Oct. 23, at 5:00 a.m. PT (8:00 a.m. ET) to discuss data in muscle-invasive bladder cancer that will be presented at the European Society for Medical Oncology (ESMO) Congress. This includ...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US74765K1051
Quantum-Si Inc
QSI
LISTED
NASDAQ
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the third quarter 2025 on Wednesday, November 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff K...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the University of Michigan. The results demonstrated the environmental and clinical benefits of End-tidal Control software and were presented at ANESTHESIOLOGY®...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics Announces $60 Million Private Placement
News Preview
LAUSANNE, Switzerland, Oct. 13, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutiona...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
News Preview
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today provided an update on preliminary data from the Phase 2 REVERT clinical trial of TTI-101 in idiopathic pulmonary fibrosis (IPF)....
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
News Preview
New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target difficult-to-treat cancers.
NORTH CHICA...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025
News Preview
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that complete data from the Phase 2b trial of rosnilimab, a pathogenic T cell depleter, in rheumatoid arthritis (RA), was accepted for a late-breaking oral p...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project
News Preview
More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US74017N1054
Precigen Inc
PGEN
LISTED
NASDAQ
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
News Preview
15 out of 18 complete responders (83%) demonstrate continued complete response with median follow-up of 36 months
Reduction in surgeries compared to year prior to treatment with PAPZIMEOS was observed in 86% of patients in Year 1, 91%...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
News Preview
First published data from a multicenter retrospective chart review study to explore the safety and efficacy of pyrimidine nucleoside and/or nucleotide therapy in patients with thymidine kinase 2 deficiency (TK2d).1
Neurology published results from a multicenter retrospective...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming CHEST 2025 Annual Meeting hosted by the American College of Chest Physicians taking place October 19-22, 2025, in Chicago. In addition, United Therapeutics will sponsor and host several events including the PHinding Pulmo...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris to Participate in Upcoming Investor Conferences
News Preview
PITTSBURGH, Oct. 13, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in November 2025.
The Company will participate in a fireside chat at the UBS Global Healthcare Conference 202...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2025 to be held from October 17-21 in Berlin, Germany. Data from more than 50 company-sponsored studies, investigator-sponsored studies, and collaborations showcase result...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
News Preview
Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral presentation
Additional presentations showcase Lilly's robust oncology p...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
News Preview
Pfizer Inc. (NYSE: PFE, “Pfizer”) will present data across its infectious disease portfolio at the upcoming IDWeek 2025 congress, held in Atlanta from October 19-22, 2025. Data in 46 abstracts from company- and collaborator-led studies will showcase significant advancements in preventing and treating infectious diseases.
“IDWeek 2025 offers a cr...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US0396971071
Ardelyx Inc
ARDX
LISTED
NASDAQ
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
News Preview
Conference call scheduled for 4:30 p.m. Eastern Time Conference call scheduled for 4:30 p.m. Eastern Time...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: NL0010872495
ProQR Therapeutics NV
PRQR
LISTED
NASDAQ
ProQR to Participate in Upcoming Investor Conferences in October 2025
News Preview
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today announced that company management will participate in the fo...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US0396971071
Ardelyx Inc
ARDX
LISTED
NASDAQ
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
News Preview
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the appointment of Sue Hohenleitner as Chief Financial Officer (CFO), effective No...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes
News Preview
MannKind Announces U.S. FDA Accepts for Review its sBLA for Inhaled Insulin in Children and Adolescents Aged 4-17...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
News Preview
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it will be presenting late-breaking Phase 2 clinical data on its antiviral influenza candidate, CD388, during ID Week 2025, ta...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US19459J1043
Collegium Pharmaceutical Inc
COLL
LISTED
NASDAQ
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
News Preview
– Collegium to Ring Nasdaq Opening Bell on October 14, 2025 – – Collegium to Ring Nasdaq Opening Bell on October 14, 2025 –...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
News Preview
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, for the treatment of adult patients with relaps...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US85916J4094
Stereotaxis Inc
STXS
LISTED
XASE
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
News Preview
ST. LOUIS and MARLBOROUGH, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced they have entered into a...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US6979471090
Palvella Therapeutics Inc
PVLA
LISTED
NASDAQ
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
News Preview
Second year proceeds granted following FDA review of annual performance progress report on Phase 3 SELVA single-arm, baseline-controlled trial; up to $2.6 million in non-dilutive funding anticipated over the grant period...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: CA05475P1099
AYR Wellness Inc
AYR.A
LISTED
CSE
AYR Wellness Announces Commencement of Restructuring Support Agreement Article 9 Proceedings
News Preview
MIAMI, Oct. 13, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR”) together with its affiliates and subsidiaries (collectively, the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces the next step of its debt restructuring process with its senior noteholders. As contemplated...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US0554771032
Bicara Therapeutics Inc.
BCAX
LISTED
NASDAQ
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
News Preview
Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCC Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCC...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration
News Preview
REDMOND, Wash., Oct. 13, 2025 /PRNewswire/ -- SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868), a global Ph2/3 registrational study of izalontamab brengitecan (iza-bren) in previously untreated triple negativ...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025
News Preview
Castle Biosciences will release Q3 2025 financial results and host conference call on Monday, Nov. 3, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
News Preview
CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events. Details of the company’s activities at these events are as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: US04335A1051
Arvinas, Inc.
ARVN
LISTED
NASDAQ
Arvinas to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress
News Preview
– Presentation to include new patient-reported outcomes (PRO) data from the Phase 3 VERITAC-2 clinical trial –...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: CA72706K1012
Planet 13 Holdings Inc.
PLTH
LISTED
CSE
Planet 13 Opens its Newest Florida Dispensary in DeLand just off the Busy I-4 Corridor Between Orlando and Daytona
News Preview
LAS VEGAS, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the opening of Florida dispensary in DeLand at 309 Woodland Blvd....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
